Features June 2015 Issue

Learn the Latest Thinking on Medications for Stent Patients

DAPT is essential to keep blood clots from forming on an arterial stent.

Learn the Latest Thinking on Medications for Stent Patients

The duration of medication use after receiving a stent depends on several factors, including the circumstances under which the stent was implanted.

Whether you receive a drug-eluting stent (DES) or a bare-metal stent (BMS), you’re going to be prescribed medications to help prevent a blood clot from forming on the stent. This condition is called stent thrombosis, and it can be life threatening, because a clot can stop blood flow and lead to a heart attack. The medication regimen designed to block stent thrombosis is called dual antiplatelet therapy (DAPT), and it consists of aspirin and an antiplatelet drug such as clopidogrel (Plavix), prasugrel (Effient), or ticagrelor (Brilinta).

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.